KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Realty Trust (HR) Other financing activities (2016 - 2025)

Historic Other financing activities for Healthcare Realty Trust (HR) over the last 16 years, with Q3 2025 value amounting to $13.1 million.

  • Healthcare Realty Trust's Other financing activities changed N/A to $13.1 million in Q3 2025 from the same period last year, while for Dec 2025 it was $13.1 million, marking a year-over-year increase of 1427692.31%. This contributed to the annual value of $13.1 million for FY2025, which is 222380.11% up from last year.
  • As of Q3 2025, Healthcare Realty Trust's Other financing activities stood at $13.1 million.
  • In the past 5 years, Healthcare Realty Trust's Other financing activities ranged from a high of $13.1 million in Q3 2025 and a low of -$5.4 million during Q2 2022
  • Its 4-year average for Other financing activities is $3.8 million, with a median of $252000.0 in 2021.
  • Per our database at Business Quant, Healthcare Realty Trust's Other financing activities skyrocketed by 12545.76% in 2021 and then tumbled by 222500.0% in 2022.
  • Quarter analysis of 4 years shows Healthcare Realty Trust's Other financing activities stood at $153000.0 in 2021, then skyrocketed by 8235.29% to $12.8 million in 2022, then plummeted by 99.29% to $91000.0 in 2023, then skyrocketed by 14276.92% to $13.1 million in 2025.
  • Its Other financing activities stands at $13.1 million for Q3 2025, versus $91000.0 for Q3 2023 and $12.8 million for Q3 2022.